SixPeaks Bio AG

SixPeaks Bio AG Debuts With $110 Million in Funding

Next-generation obesity company with potential best- and first-in-class assets launched by Versant Ventures–

Emerges from stealth with $30 million in Series A financing and a strategic collaboration with AstraZeneca providing up to $80 million